| 000 | 01040 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512082153.0 | ||
| 264 | 0 | _c19850319 | |
| 008 | 198503s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEdlavitch, S A | |
| 245 | 0 | 0 |
_aA potential use of the National Death Index for postmarketing drug surveillance. _h[electronic resource] |
| 260 |
_bJAMA _cMar 1985 |
||
| 300 |
_a1292-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDeath Certificates |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 |
_aEvaluation Studies as Topic _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInformation Systems _xorganization & administration |
| 650 | 0 | 4 | _aMortality |
| 650 | 0 | 4 | _aNational Center for Health Statistics, U.S. |
| 650 | 0 | 4 |
_aProduct Surveillance, Postmarketing _xmethods |
| 650 | 0 | 4 |
_aRegistries _xorganization & administration |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aFeinleib, M | |
| 700 | 1 | _aAnello, C | |
| 773 | 0 |
_tJAMA _gvol. 253 _gno. 9 _gp. 1292-5 |
|
| 999 |
_c3974540 _d3974540 |
||